Darren Dasburg, a long-tenured executive at GSK, Medimmune/AZ, well-regarded consultant, and currently Chief Business Officer, CRISPR Biotech, didn’t write the book on outsourcing. He did, though, design and teach the defining class on the subject. The “Outsourcing Master Class” is a capstone-case-review, team-based course sanctioned by the International Association of Outsourcing Professionals (IAOP). With so many new professionals entering the drug industry, and new fields like cell-and-gene on the upswing, Dasburg offered Outsourced Pharma Chief Editor Louis Garguilo the opportunity to review that master class for our readers. Whether a sponsor or provider, these time-tested outsourcing fundamentals offer you a blueprint to keep teams working together on both sides. Dasburg also took the opportunity to update some of the class modules, and provides an intriguing case study from his career that includes a strategic “outsourcing” relationship between Merck and Medimmune.